BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Song Q, Zhang X. The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC. Biomedicines 2022;10:524. [DOI: 10.3390/biomedicines10030524] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Ma Y, Xiu W, Wang X, Yang Q. Extraction of raspberry ketone from red raspberry and its intervention in the non-alcoholic fatty liver disease. Appl Biol Chem 2022;65:78. [DOI: 10.1186/s13765-022-00745-3] [Reference Citation Analysis]
2 Pezzino S, Sofia M, Faletra G, Mazzone C, Litrico G, La Greca G, Latteri S. Gut–Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome. Biology 2022;11:1622. [DOI: 10.3390/biology11111622] [Reference Citation Analysis]
3 Zhang M, Li RW, Yang H, Tan Z, Liu F. Recent advances in developing butyrogenic functional foods to promote gut health. Critical Reviews in Food Science and Nutrition 2022. [DOI: 10.1080/10408398.2022.2142194] [Reference Citation Analysis]
4 Nguyen HT, Gu M, Werlinger P, Cho J, Cheng J, Suh J. Lactobacillus sakei MJM60958 as a Potential Probiotic Alleviated Non-Alcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet by Modulating Lipid Metabolism, Inflammation, and Gut Microbiota. IJMS 2022;23:13436. [DOI: 10.3390/ijms232113436] [Reference Citation Analysis]
5 Chen X, Liu M, Tang J, Wang N, Feng Y, Ma H. Research Progress on the Therapeutic Effect of Polysaccharides on Non-Alcoholic Fatty Liver Disease through the Regulation of the Gut–Liver Axis. IJMS 2022;23:11710. [DOI: 10.3390/ijms231911710] [Reference Citation Analysis]
6 Jeong MK, Min BH, Choi YR, Hyun JY, Park HJ, Eom JA, Won SM, Jeong JJ, Oh KK, Gupta H, Ganesan R, Sharma SP, Yoon SJ, Choi MR, Kim DJ, Suk KT. Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease. Foods 2022;11:2703. [PMID: 36076888 DOI: 10.3390/foods11172703] [Reference Citation Analysis]
7 Zunica ERM, Heintz EC, Axelrod CL, Kirwan JP. Obesity Management in the Primary Prevention of Hepatocellular Carcinoma. Cancers (Basel) 2022;14:4051. [PMID: 36011044 DOI: 10.3390/cancers14164051] [Reference Citation Analysis]
8 Palma R, Pronio A, Romeo M, Scognamiglio F, Ventriglia L, Ormando VM, Lamazza A, Pontone S, Federico A, Dallio M. The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications. JCM 2022;11:3649. [DOI: 10.3390/jcm11133649] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]